Nuevas Drogas Psicoactivas

Helen Dolengevich-Segal, Beatriz Rodríguez Salgado, Jorge Gómez-Arnau Ramírez, Daniel Sánchez-Mateos

Resumen


Carta al editor

Palabras clave


Drogas psicoactivas

Texto completo:

PDF PDF (English)

Referencias


Davey, Z., Schifano, F., Corazza, O., Deluca, P. y Psychonaut Web Mapping Group. (2012). e-Psychonauts: conducting research in online drug forum communities. Journal of Mental Health, 21, 386-94.

Delegación del Gobierno para el Plan Nacional sobre Drogas (2015). Encuesta sobre alcohol y drogas en la población general en España (EDADES 2013/2014). Ministerio de Sanidad, Servicios Sociales e Igualdad.

Dolengevich-Segal, H., Rodríguez-Salgado, B., Gómez-Arnau, J., Rabito-Alcón, M. F., y Correas-Lauffer, J. (2014). Psychoactive substance use in the Internet era. Revista de Patología Dual, 1, 3-9.

European Monitoring Centre for Drugs and Drug Addiction (2015). New psychoactive substances in Europe. An update from the EU Early Warning System. Publications Office of the European Union, Luxembourg.

Jünger, E. (1987). Visita a Godenholm. Madrid: Alianza editorial (trabajo original publicado en 1952).

Kersten, B. P. y McLaughlin, M.E. (2015). Toxicology and management of novel psychoactive drugs. Journal of Pharmacy Practice, 28, 50-65. doi: 10.1177/0897190014544


Siddiqi, S., Verney, C., Dargan, P. y Wood, D. M. (2015). Understanding the availability, prevalence of use, desired effects, acute toxicity and dependence potential of the novel opioid MT-45. Clinical Toxicology (Philadelphia), 53, 54-59. doi: 10.3109/15563650.2014.983239.

Szerman, N., Martínez-Raga, J., Peris, L., Roncero, C., Basurte, I., Vega, P. y Casas, M. (2013). Rethinking Dual Disorders/Pathology. Addictive Disorders & Their Treatment, 12, 1-10. doi: 10.1097/ADT.0b013e31826e7b6a.

United Nations Office on Drugs and Crime (2013). The Challenge of New Psychoactive Substances. Disponible en: http://www.unodc.org/documents/scientific/NPS _2013_SMART.pdf

Volkow, N. (2001). Drug abuse and mental illness: progress in understanding comorbidity. American Journal of Psychiatry, 158, 1181–1183.

Wood, D. M., Sedefov, R., Cunningham, A., Dargan, P. I. (2015). Prevalence of use and acute toxicity associated with the use of NBOMe drugs. Clinical Toxicology (Philadelphia), 53, 85-92. doi: 10.3109/15563650.2015.1004179.




DOI: https://doi.org/10.20882/adicciones.709

Enlaces refback

  • No hay ningún enlace refback.